Skip to main content

Table 1 Baseline characteristics of 2592 HIV-infected patients

From: Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings

Baseline characteristics

Valuea

Median (IQR) age, years

35.8 (29.9–42.5)

Male

1883 (72.6)

HIV exposure

 Heterosexual

1456 (56.2)

 Homosexual

778 (30.0)

 Intravenous drug use

93 (3.6)

 Other

265 (10.2)

Median (IQR) body mass index, kg/m2

21.1 (19.0–23.4)

  Missing

683 (26.4)

Anemia

 No, n (% tested)

1208 (50.7)

 Yes, n (% tested)

1176 (49.3)

 Unknown

208 (8.0)

Hepatitis B surface antigen

 Negative, n (% tested)

1925 (89.2)

 Positive, n (% tested)

232 (10.8)

 Unknown

435 (16.8)

Hepatitis C antibody

 Negative, n (% tested)

1844 (91.7)

 Positive, n (% tested)

168 (8.3)

 Unknown

580 (22.4)

Syphilis serology

 Negative, n (% tested)

825 (80.4)

 Positive, n (% tested)

201 (19.6)

 Unknown

1566 (60.4)

Median (IQR) duration of HIV diagnosis, months

4.3 (1.4–29.2)

  Missing

29 (1.1)

HIV subtype

 CRF01_AE, n (% tested)

796 (75.1)

 B, n (% tested)

173 (16.3)

 Other, n (% tested)

91 (8.6)

 Unknown

1532 (59.1)

Median (IQR) HIV RNA, copies/mL

100,000 (34,045–301,075)

Median (IQR) CD4 count, cells/mm3

147 (50–248)

  Missing

106 (4.1)

Median (IQR) CD8 count, cells/mm3

753 (485–1103)

  Missing

1268 (48.9)

Median (IQR) CD4:CD8 ratio

0.19 (0.09–0.32)

  Missing

1268 (48.9)

Median (IQR) total lymphocyte count, cells/mm3

1472 (1000–2005)

  Missing

286 (11.0)

Prior AIDS illness

 No

1698 (65.5)

 Yes

894 (34.5)

  1. IQR interquartile range
  2. a Values are n (% total) unless otherwise specified